Labcorp Holdings [LH] vs Thermo Fisher [TMO] Detailed Stock Comparison

Labcorp Holdings Inc.

NYSE
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Labcorp Holdings Inc. wins in 10 metrics, Thermo Fisher Scientific Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Labcorp Holdings Inc. Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) 25.30 25.84 Labcorp Holdings Inc.
Price-to-Book Ratio 2.53 3.31 Labcorp Holdings Inc.
Debt-to-Equity Ratio 75.56 82.91 Labcorp Holdings Inc.
PEG Ratio 1.55 2.29 Labcorp Holdings Inc.
EV/EBITDA 12.70 19.02 Labcorp Holdings Inc.
Profit Margin (TTM) 6.28% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) 10.55% 17.89% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) 10.55% 17.89% Thermo Fisher Scientific Inc.
Return on Equity 10.51% 13.52% Thermo Fisher Scientific Inc.
Return on Assets (TTM) 5.12% 5.00% Labcorp Holdings Inc.
Free Cash Flow (TTM) $1.21B $6.29B Thermo Fisher Scientific Inc.
Dividend Yield 1.00% 0.38% Labcorp Holdings Inc.
1-Year Return 4.45% 22.27% Thermo Fisher Scientific Inc.
Price-to-Sales Ratio (TTM) 1.56 3.86 Labcorp Holdings Inc.
Enterprise Value $27.84B $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 2.00 4.75 Labcorp Holdings Inc.
Gross Profit Margin (TTM) 28.25% N/A N/A
Revenue per Share (TTM) $168 $120 Labcorp Holdings Inc.
Earnings per Share (Diluted) $10.47 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 0.99 0.97 Thermo Fisher Scientific Inc.
Short % of Float 3.90% 1.22% Thermo Fisher Scientific Inc.

Labcorp Holdings Inc. vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

LH
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Labcorp Holdings Inc.0.47%-0.27%1.87%-10.03%-3.08%2.42%
Thermo Fisher Scientific Inc.-1.69%7.56%4.21%-5.21%-16.94%-18.64%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Labcorp Holdings Inc.4.45%39.51%13.65%134.84%211.71%405.07%
Thermo Fisher Scientific Inc.22.27%-5.31%9.75%222.18%684.25%1,233.99%

Performance & Financial Health Analysis: Labcorp Holdings Inc. vs Thermo Fisher Scientific Inc.

MetricLHTMO
Market Information
Market Cap i$21.83B$174.55B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i623,8552,356,220
90 Day Avg. Volume i582,0122,071,517
Last Close$258.92$473.95
52 Week Range$241.81 - $293.72$385.46 - $643.99
% from 52W High-11.85%-26.40%
All-Time High$293.72 (Oct 21, 2025)$672.34 (Dec 27, 2021)
% from All-Time High-11.85%-29.51%
Growth Metrics
Quarterly Revenue Growth0.06%0.06%
Quarterly Earnings Growth0.15%0.10%
Financial Health
Profit Margin (TTM) i0.06%0.15%
Operating Margin (TTM) i0.11%0.18%
Return on Equity (TTM) i0.11%0.14%
Debt to Equity (MRQ) i75.5682.91
Cash & Liquidity
Book Value per Share (MRQ)$104.86$141.96
Cash per Share (MRQ)$6.46$8.75
Operating Cash Flow (TTM) i$1.64B$8.29B
Levered Free Cash Flow (TTM) i$966.63M$5.51B
Dividends
Last 12-Month Dividend Yield i1.00%0.38%
Last 12-Month Dividend i$2.88$1.76

Valuation & Enterprise Metrics Analysis: Labcorp Holdings Inc. vs Thermo Fisher Scientific Inc.

MetricLH (Apr 24, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i25.3025.84
Forward P/E i13.7417.16
PEG Ratio i1.552.29
Price to Sales (TTM) i1.563.86
Price to Book (MRQ) i2.533.31
Market Capitalization
Market Capitalization i$21.83B$174.55B
Enterprise Value i$27.84B$214.76B
Enterprise Value Metrics
Enterprise to Revenue i2.004.75
Enterprise to EBITDA i12.7019.02
Risk & Other Metrics
Beta i0.990.97
Book Value per Share (MRQ) i$104.86$141.96

Financial Statements Comparison: Labcorp Holdings Inc. vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLH (2025)TMO (2025)
Revenue/Sales i13.95B44.56B
Cost of Goods Sold i9.94B26.32B
COGS % of Revenue i71.2%59.1%
Gross Profit i4.01B18.24B
Gross Margin i28.8%40.9%
Research & Development iN/A1.40B
Operating Income (EBIT) i1.52B8.11B
Operating Margin i10.9%18.2%
EBITDA i2.13B11.86B
EBITDA Margin i15.3%26.6%
Pre-Tax Income i1.11B7.31B
Pre-Tax Income % of Revenue i7.9%16.4%
Income Tax i229.80M547.00M
Income Tax % of Revenue i1.6%1.2%
Net Income (Profit) i877.70M6.72B
Profit Margin i6.3%15.1%

Balance Sheet & Liquidity Metrics

MetricLH (2025)TMO (2025)
Cash & Equivalents i532.30M9.85B
Total Current Assets i4.02B28.71B
Total Current Assets % of Revenue i28.8%64.4%
Total Current Liabilities i2.82B15.19B
Total Current Liabilities % of Revenue i20.2%34.1%
Long-Term Debt i5.83B35.85B
Long-Term Debt % of Revenue i41.8%80.5%
Total Shareholders Equity i8.64B53.54B
Retained Earnings i8.64B59.16B
Retained Earnings % of Revenue i61.9%132.8%
Property, Plant & Equipment i803.90M0

Cash Flow Statement Comparison

MetricLH (2025)TMO (2025)
Operating Cash Flow i1.99B7.82B
Operating Cash Flow % of Revenue i14.3%17.5%
Capital Expenditures iN/A-1.48B
Free Cash Flow i1.21B6.29B
FCF Margin i8.6%14.1%
Debt Repayment i-1.06B-3.51B
Common Stock Repurchase i-450.00M-3.00B

Short Interest & Institutional Ownership Analysis

MetricLHTMO
Shares Short i3.19M4.54M
Short Ratio i5.832.38
Short % of Float i3.90%1.22%
Shares Outstanding i82.20M371.62M
Float Shares i82.00M371.07M
% Held by Insiders i0.36%0.17%
% Held by Institutions i100.64%95.23%
% Held by Public i-1.00%4.60%

Dividend Analysis & Yield Comparison: Labcorp Holdings Inc. vs Thermo Fisher Scientific Inc.

MetricLHTMO
Last 12-Month Dividend i$2.88$1.76
Last 12-Month Dividend Yield i1.00%0.38%
3-Year Avg Annual Dividend i$3.09$1.60
3-Year Avg Dividend Yield i0.31%0.08%
3-Year Total Dividends i$9.26$4.80
Ex-Dividend DateFeb 27, 2026Mar 13, 2026